- Release Date: 31/01/25 16:29
- Summary: Proposed issue of securities - PAR
- Price Sensitive: No
- Download Document 19.99KB
- Forums
- ASX - By Stock
- PAR
- Ann: Proposed issue of securities - PAR
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
30.5¢

Ann: Proposed issue of securities - PAR
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.2M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 30.5¢ | $39.69K | 128.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 229318 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 9167 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 229318 | 0.300 |
21 | 451852 | 0.295 |
20 | 281212 | 0.290 |
11 | 63534 | 0.285 |
10 | 243485 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 9167 | 2 |
0.310 | 40369 | 10 |
0.315 | 35252 | 7 |
0.320 | 60139 | 7 |
0.325 | 102163 | 7 |
Last trade - 10.42am 22/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online